Evidence map›Paper›PMID 22675126›Full record

ArticleJournal of clinical microbiology2012

Molecular epidemiology of Aspergillus fumigatus isolates harboring the TR34/L98H azole resistance mechanism.

Simone M T Camps, Antonius J M M Rijs, Corné H W Klaassen, Jacques F Meis, Céline M O'Gorman, Paul S Dyer, Willem J G Melchers, Paul E Verweij

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 129 citations in OpenAlex.

  1. Global epidemiology of azole resistance inJAC-antimicrobial resistance · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Epidemiology of Clinically SignificantInfection and drug resistance · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Phylogenetic Distribution ofMicrobiology spectrum · 2021
    Article
  13. Article
  14. Review
  15. Review
  16. Studies in mycology · 2021
    Review
  17. Article
  18. Article
  19. Review
  20. Molecular Epidemiology ofJournal of fungi (Basel, Switzerland) · 2021
    Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Simone M T CampsRadboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Antonius J M M Rijs
Corné H W Klaassen
Jacques F Meis
Céline M O'Gorman
Paul S Dyer
Willem J G Melchers
Paul E Verweij
Radboud University Nijmegen · NLRadboud University Medical Center · NLUniversity of Nottingham · GBCanisius-Wilhelmina Ziekenhuis · NL

Funding

Wellcome Trust
6 · The paper itself

Abstract

A rapid emergence of azole resistance has been observed in Aspergillus fumigatus in The Netherlands over the past decade. The dominant resistance mechanism appears to be of environmental origin and involves the TR(34)/L98H mutations in cyp51A. This resistance mechanism is now also increasingly being found in other countries. Therefore, genetic markers were used to gain more insights into the origin and spread of this genotype. Studies of 142 European isolates revealed that those with the TR(34)/L98H resistance mechanism showed less genetic variation than azole-susceptible isolates or those with a different genetic basis of resistance and were assigned to only four CSP (putative cell surface protein) types. Sexual crossing experiments demonstrated that TR(34)/L98H isolates could outcross with azole-susceptible isolates of different genetic backgrounds, suggesting that TR(34)/L98H isolates can undergo the sexual cycle in nature. Overall, our findings suggest a common ancestor of the TR(34)/L98H mechanism and subsequent migration of isolates harboring TR(34)/L98H across Europe.

Indexed as

Drug Resistance, FungalAntifungal AgentsAspergillosisAspergillus fumigatusAzolesCrosses, GeneticCytochrome P-450 Enzyme SystemDNA, FungalEuropeFungal ProteinsGenetic VariationHumansMicrobial Sensitivity TestsMolecular EpidemiologyMutationRecombination, GeneticAntifungal AgentsAzolescytochrome P-450 CYP51A, AspergillusCytochrome P-450 Enzyme SystemDNA, FungalFungal Proteins

Identifiers

PMID22675126
PMCPMC3421523
OpenAlexW2156176896

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.